Msx2、topoⅡ-α、HPV16及VEGF在鼻内翻性乳头状瘤中的定量及意义

张峻峥, 杨一兵, 汤勇, 等. Msx2、topoⅡ-α、HPV16及VEGF在鼻内翻性乳头状瘤中的定量及意义[J]. 临床耳鼻咽喉头颈外科杂志, 2014, 28(23): 1819-1823. doi: 10.13201/j.issn.1001-1781.2014.23.001
引用本文: 张峻峥, 杨一兵, 汤勇, 等. Msx2、topoⅡ-α、HPV16及VEGF在鼻内翻性乳头状瘤中的定量及意义[J]. 临床耳鼻咽喉头颈外科杂志, 2014, 28(23): 1819-1823. doi: 10.13201/j.issn.1001-1781.2014.23.001
ZHANG Junzheng, YANG Yibing, TANG Yong, et al. The quantification and significance of muscle segment homeobox gene Msx2,human topoisomerase Ⅱ-α,HPV 16 and VEGF in sinonasal inverted papilloma[J]. J Clin Otorhinolaryngol Head Neck Surg, 2014, 28(23): 1819-1823. doi: 10.13201/j.issn.1001-1781.2014.23.001
Citation: ZHANG Junzheng, YANG Yibing, TANG Yong, et al. The quantification and significance of muscle segment homeobox gene Msx2,human topoisomerase Ⅱ-α,HPV 16 and VEGF in sinonasal inverted papilloma[J]. J Clin Otorhinolaryngol Head Neck Surg, 2014, 28(23): 1819-1823. doi: 10.13201/j.issn.1001-1781.2014.23.001

Msx2、topoⅡ-α、HPV16及VEGF在鼻内翻性乳头状瘤中的定量及意义

  • 基金项目:

    云南省应用基础研究面上项目(No:2010ZC124)

详细信息
    通讯作者: 杨一兵,E-mail:369300770@qq.com
  • 中图分类号: R730.261

The quantification and significance of muscle segment homeobox gene Msx2,human topoisomerase Ⅱ-α,HPV 16 and VEGF in sinonasal inverted papilloma

More Information
  • 目的:探讨Msx2、topoⅡ-α、HPV16及VEGF在鼻内翻性乳头状瘤(SNIP)组织中的定量及意义,研究上述四种因子之间是否具有相关性,进一步确定Msx2和topoⅡ-α在SNIP恶变发生、发展中的关系。方法:采用实时荧光定量聚合酶链反应(RT-qPCR)分别检测Msx2、topoⅡ-α、VEGF及HPV16在13例SNIP,10例鼻息肉(INP),10例鼻腔-鼻窦鳞状细胞癌组织(NSCC)中的表达。其中SNIP根据病理形态分为轻度不典型增生组、中度不典型增生组和重度不典型增生组。结果:SNIP和NSCC组织中Msx2、topoⅡ-α、HPV16及VEGF的表达均显著高于INP(P<0.05)。Msx2、topoⅡ-α、VEGF及HPV16在SNIP的3个病理形态组之间的表达差异均有统计学意义(P<0.05)。采用Pearson相关系数得出HPV16、topoⅡ-α、VEGF、Msx2之间两两比较均呈正相关性(P<0.05)。结论:Msx2和topoⅡ-α在SNIP恶变的发生、发展中起重要作用,有可能成为SNIP和NSCC基因治疗的新靶点。
  • 加载中
  • [1]

    ABATE-SHEN C.Deregulated homeobox gene expression in cancer:cause or consequence[J]?Nat Rev Cancer, 2002, 2:777-785.

    [2]

    ZHAI Y, IURA A, YEASMIN S, et al.MSX2 is an oncogenic downstream target of activated WNT signaling in ovarian endometrioid adenocarcinoma[J].Ncogene, 2011, 30:4152-4162.

    [3]

    HAMADA S, SATOH K, KIMURA K, et al.MSX2 overexpression inhibits gemcitabine-induced caspase-3activity in pancreatic cancer cells[J].World J Gastroenterol, 2005, 11:6867-6870.

    [4]

    MARUYA S, SHIRASAKI T, NAGAKI T, et al.Differential expression of topoisomeraseⅡalpha protein in salivary gland carcinomas:histogenetic and prognostic implications[J].BMC Cancer, 2009, 9:72-72.

    [5]

    孔慧, 关庆捷, 孙秀珍, 等.VEGF及其受体的表达对鼻内翻性乳头状瘤恶变倾向预测的意义[J].临床耳鼻咽喉头颈外科杂志, 2012, 26 (8):337-342.

    [6]

    KIM S G, LEE O Y, CHOI J W, et al.Pattern of expression of cell cycle-related proteins in malignant transformation of sinonasal inverted papilloma[J].Am J Rhinol Allergy, 2011, 25:75-81.

    [7]

    SUZUKI M, TANAKA M, IWASE T, et al.Overexpression of HOX-8the human homologue of the mouse Hox-8homeobox gene, in human tumors[J].Biochem Biophys Res Commun, 1993, 194:187-193.

    [8]

    DEPONDT J, SHABANA EL-H, WALKER F, et al.Nasal inverted papilloma expresses the muscle segment homeobox gene Msx2:possible prognostic implications[J].Hum Pathol, 2008, 39:350-358.

    [9]

    YOSHIZAWA T, TAKIZAWA F, ⅡZAWA F, et al.Homeobox protein MSX2 acts as a molecular defense mechanism for preventing os-si fication in ligamentfibroblasts[J].Mol Cell Biol, 2004, 24:3460-3472.

    [10]

    LEE H L, YI T, WOO K M, et al.Msx2 mediates the inhibitory action of TNF-α on osteoblast differentiation[J].Exp Mol Med, 2010, 42:437-445.

    [11]

    LYNCH B J, GUINEE DG Jr, HOLDEN J A.Human DNA topoisomeraseⅡ-alpha:a new marker of cell proliferation in invasive breast cancer[J].Hum Pathol, 1997, 28:1180-1188.

    [12]

    MANO M S, ROSA D D, DE AZAMBUJA E, et al.The 17q12-q21 amplicon:Her2 and topoisomerase-Ⅱα and their importance to the biology of solid tumours[J].Cancer Treat Rev, 2007, 33:64-77.

    [13]

    GALLI R, BINDA E, ORFANELLI U, et al.Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma[J].Cancer Res, 2004, 64:7011-7021.

    [14]

    吴琼芳, 杨一兵, 吴锡芳, 等.Msx2和topoⅡ-a在鼻内翻性乳头状瘤中的表达及意义[J].临床耳鼻咽喉头颈外科杂志, 2012, 26 (8):343-346.

    [15]

    SENGER D R, VAN DE WATER L, BROWN L F, et al.Vascular permeability factor (VPF, VEGF) in tumor biology[J].Cancer Metastasis Rev, 1993, 12:303-324.

    [16]

    陈庆云, 卞美璐, 陈志华, 等.宫颈癌癌前病变中人乳头状瘤病毒16整合状态的检测[J].中华医学杂志, 2005, 85 (6):400-404.

    [17]

    TRIBIUS S, HOFFMANN A S, BASTROP S.HPV status in patients with head and neck of carcinoma of unknown primary site:HPV, tobacco smoking, and outcome[J].Oral Oncol, 2012, 48:1178-1184.

    [18]

    钟振华, 闫艾慧, 姜菲菲, 等.人乳头状瘤病毒感染与鼻内翻性乳头状瘤的发病及恶变关系的研究[J].临床耳鼻咽喉头颈外科杂志, 2010, 24 (5):209-211.

  • 加载中
计量
  • 文章访问数:  162
  • PDF下载数:  203
  • 施引文献:  0
出版历程
收稿日期:  2013-10-27

目录